Inventor · disambiguated record
Katherine Ann Vousden
Also filed as: VOUSDEN KATHERINE · VOUSDEN KATHERINE A · VOUSDEN KATHERINE ANN
8 granted patents·8 pending applications·20 citations·filing 2003–2025
82Inventor score
Top patents by PatentIndex Score
16 records- 0188US11072652B2ILT7 binding molecules and methods of using the sameVIELA BIO INC·Filed 2017·Granted Jul 27, 2021·5 cites·24 claims
- 0287US11306145B2Binding molecules specific for FcγRIIA and uses thereofVIELA BIO INC·Filed 2017·Granted Apr 19, 2022·10 cites·13 claims
- 0385US11673950B2ILT7 binding molecules and methods of using the sameVIELA BIO INC·Filed 2021·Granted Jun 13, 2023·1 cites·22 claims
- 0481US10668150B2IL33 form, mutated forms of IL33, antibodies, assays and methods of using the sameMEDIMMUNE LTD·Filed 2016·Granted Jun 2, 2020·3 cites·13 claims
- 0580US12421314B2Binding molecules specific for fcγRIIA and uses thereofHORIZON THERAPEUTICS IRELAND DAC·Filed 2023·Granted Sep 23, 2025·0 cites·10 claims
- 0678US11738081B2Polynucleotides encoding IL33 antibodies and methods of using the sameMEDIMMUNE LTD·Filed 2020·Granted Aug 29, 2023·1 cites·15 claims
- 0775US12291579B2Anti-phosphocholine antibodies and methods of use thereofOXITOPE PHARMA B V·Filed 2024·Granted May 6, 2025·0 cites·20 claims
- 0874US11746153B2Binding molecules specific for FcγRIIA and uses thereofVIELA BIO INC·Filed 2022·Granted Sep 5, 2023·0 cites·9 claims
- 0972US2024016929A1Il33 antibodies and methods of using the sameMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 1072US2023250167A1Ilt7 binding molecules and methods of using the sameVIELA BIO INC·Filed 2023·Application pending·0 cites
- 1164US2024199761A1Treatment of autoimmune diseaseASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1260US2006240493A1Cca1 as an antifungal targetVOUSDEN KATHERINE A·Filed 2003·Application pending·0 cites
- 1357US2009209498A1Methods of Treatment Using CCA1 InhibitorsUCB PHARMA SA·Filed 2009·Application pending·0 cites
- 1456US2025320312A1Anti-phosphocholine antibodies and methods of use thereofOXITOPE PHARMA B V·Filed 2025·Application pending·0 cites
- 1556US2012135453A1Methods of Treatment Using CCA1 InhibitorsVOUSDEN KATHERINE ANN·Filed 2011·Application pending·0 cites
- 1651US2006172368A1CGT1 as an antifungal targetVOUSDEN KATHERINE A·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katherine Ann Vousden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →